Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse

By Lagging Martin  

Scandinavian Journal of Gastroenterology, Vol. 48, Iss. 7, 2013-07 ,pp. : 839-847

Informa Healthcare

Access to resources Recommend Favorite

Early Viral Response Predicts the Efficacy of Antiviral Triple Therapy with Simeprevir, Peg-Interferon and Ribavirin in Patients Infected with Hepatitis C Virus Genotype 1

By  

Digestive Diseases, Vol. 33, Iss. 6, 2015-0 ,pp. : 708-714

Karger

Access to resources Recommend Favorite

Relevance of the Core 70 and IL-28B polymorphism and response-guided therapy of peginterferon alfa-2a ± ribavirin for chronic hepatitis C of Genotype 1b: a multicenter randomized trial, ReGIT-J study

By Nishiguchi Shuhei   Enomoto Hirayuki   Aizawa Nobuhiro   Nishikawa Hiroki   Osaki Yukio   Tsuda Yasuhiro   Higuchi Kazuhide   Okazaki Kazuichi   Seki Toshihito   Kim Soo   Hongo Yasushi   Jyomura Hisato   Nishida Naoshi   Kudo Masatoshi  

Journal of Gastroenterology, Vol. 49, Iss. 3, 2014-03 ,pp. : 492-501

Springer Publishing Company

Access to resources Recommend Favorite

Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) and ribavirin

By Foster Graham   Fried Michael   Hadziyannis Stephanos   Messinger Diethelm   Freivogel Klaus   Weiland Ola  

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 2, 2007-01 ,pp. : 247-255

Informa Healthcare

Access to resources Recommend Favorite

Inflammatory markers neopterin and alanine aminotransferase in HCV patients treated with HCV NS3•4A protease inhibitor telaprevir (VX-950) and/or peginterferon alfa-2a

By Gelderblom Huub   Zeuzem Stefan   Weegink Christine   Forestier Nicole   Mcnair Lindsay   Purdy Susan   Dijkgraaf Marcel   Jansen Peter   Reesink Henk  

Scandinavian Journal of Gastroenterology, Vol. 43, Iss. 9, 2008-01 ,pp. : 1122-1127

Informa Healthcare

Access to resources Recommend Favorite